Project Grant 2423477
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Somerville, MA 02144, USA
Similar Awards
This NSF Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to President and Fellows of Harvard College (Harvard University) provides $550,000 in funding from August 1, 2024 to July 31, 2026 to develop a minimally-invasive, catheter-based additive manufacturing platform capable of creating customized medical implants directly inside the human body. The project aims to transform the field of medical implants by enabling on-demand fabrication of personalized 3D-printed...
The National Science Foundation (NSF) awarded a Project Grant through its Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) to Georgia Tech Research Corporation in the amount of $249,689 for the project "3D Printed Tissue Implants for Facial Surgery." The project aims to develop a platform for 3D printing tissue implants for facial surgery, enabling the design and rapid manufacturing of implants for tissue reconstruction. The work will involve evaluating the impact...
The National Science Foundation (NSF) awarded a $305,000 SBIR Phase I Project Grant to Novaurum Biosciences Incorporated under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The grant supports the development of a novel mammalian cell-based nano-biological coating for implantable medical devices to address the significant health and economic burden associated with implant-related infections. The key objectives are to: (1) characterize nanoparticles produced by...
This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $274,811 to Anova Biomedical, Inc. to develop 3D printed personalized vascular grafts using novel elastomeric resins. The key objectives are to: 1) develop and characterize the novel 3D printing resin for producing personalized, elastic, and bioresorbable vascular grafts; 2) demonstrate the ability to 3D print vascular prosthetics using patient CT...
This National Science Foundation (NSF) SBIR Phase I Project Grant award of $304,906 to Seabird Lifesciences LLC, a minority-owned small business in Milton, MA, aims to develop an innovative bioprinting process for creating vascular grafts that closely mimic the properties of natural blood vessels. The project, funded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, seeks to address limitations of current synthetic and biological vascular grafts by utilizing a...
The National Science Foundation (NSF) awarded a $979,298 Cooperative Agreement under its Technology, Innovation, and Partnerships (CFDA 47.084) program to Asante Bio LLC, a small disadvantaged business, to develop a Multi-Axial Filament Winding Process (3DMF) for biomanufacturing high-performance orthobiologic implants for rotator cuff repair. This two-year project aims to optimize the manufacturing, surgical delivery, biomechanical performance, and biocompatibility of the 3DMF implants, which...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Magsorbeo Biomedical Corp aims to develop a bioabsorbable magnesium alloy for maxillofacial fixation. The project will demonstrate the feasibility of a customizable absorption profile for this alloy, which could reduce the need for secondary hardware removal surgeries. Key technical objectives include optimizing the alloy's microstructure and absorption behavior,...
This $256,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program will support the development of additive manufacturing techniques for soft tissue repair. Asante Bio LLC will receive funding to design and engineer a novel 3D microfiber printer capable of assembling synthetic biopolymer filaments into fibrous, flexible implants that promote soft tissue healing. Through this six-month award ending November 2022, Asante Bio will optimize...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award to Reselute, Inc. provides $998,921 to develop a novel implantable orthopedic medical device and procedure to reduce recovery duration and infection risks associated with severe traumatic fractures of the long bones. The project aims to advance a 3D-printed, antibiotic-releasing intramedullary nail to improve upon current standard-of-care implants that are prone to...
This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to Amphix Bio Inc. to develop scalable manufacturing methods for a novel supramolecular polymer-based spinal implant. The project aims to enable safer, simpler, and lower-cost spinal fusion surgery by advancing this regenerative medicine technology. The key deliverables include scaling up the production of the...